Cepheid - Conference Presentation Calls

Cepheid announced consolidated unaudited earnings results for the third quarter and nine months September 30, 2009. For the quarter, the company reported total revenues of 41,635,000 compared to $44,915,000 for the same period a year ago. Loss from operations was $4,200,000 compared to $6,336,000 for the same period a year ago. Loss before income tax benefit was $4,084,000 compared to $7,242,000 for the same period a year ago. Net loss was $3,839,000 or $0.07 diluted per share compared to $6,628,000 or $0.12 diluted per share for the same period a year ago. Non-GAAP net loss was $71,000 or $0.00 diluted per share compared to $2,474,000 or $0.04 diluted per share for the same period a year ago. For the nine months, the company reported total revenues of $121,423,000 compared to $131,798,000 for the same period a year ago. Loss from operations was $19,331,000 compared to $17,658,000 for the same period a year ago. Loss before income tax benefit was $18,684,000 compared to $17,091,000 for the same period a year ago. Net loss was $18,220,000 or $0.31 diluted per share compared to $16,341,000 or $0.29 diluted per share for the same period a year ago. Net cash provided by operating activities was $11,678,000 compared to $4,592,000 for the same period a year ago. Capital expenditures were $7,119,000 compared to $12,293,000 for the same period a year ago. Non-GAAP net loss was $5,346,000 or $0.09 diluted per share compared to $4,647,000 or $0.08 diluted per share for the same period a year ago. For the fiscal year ending December 31, 2009, the company expects total revenue to be in the range of $165 to $169 million, Net loss in the range of $0.42 to $0.45 per share and Non-GAAP net loss in the range of $0.13 to $0.16 per share.

Cepheid announced that it has appointed Nicolaas Arnold as executive vice president of worldwide commercial operations, effective October 14, 2009. Robert Koska, Cepheid's senior vice president of North American Commercial Operations, and Rika Dutau, vice president and managing director of European Commercial Operations, will continue in their roles, reporting to Mr. Arnold. Arnold joins Cepheid from Siemens and, previously from Diagnostic Products Corporation which was acquired by Siemens in 2006. Building on his academic and early research experience in clinical laboratories, Mr. Arnold brings more than 25 years of global sales and marketing experience in diagnostics to Cepheid. Most recently, Arnold was regional vice president for Siemens Healthcare Diagnostics in Northwest Europe with responsibility for molecular diagnostics, central lab and point of care sales.